Cite
MLA Citation
N.A. Abdul Halim et al.. “Topic: AS08-Treatment/AS08a-Current treatment options - Higher risk MDS: SINGLE-CENTER EXPERIENCE OF AZACITIDINE-VENETOCLAX IN SECONDARY ACUTE MYELOID LEUKEMIA (AML), ARISING FROM MYELODYSPLASTIC SYNDROME (MDS), MYELOPROLIFERATIVE NEOPLASM (MPN) OR MDS/MPN OVERLAP.” Leukemia research, vol. 128, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100184744878.0x000053